COVID-19 vaccination for 18-44 age group halted in these states, know the reasons behind the decision
news 5 min read
New Delhi: Due to the acute shortage of COVID-19 vaccines in the country, many states have temporarily suspended the vaccination drive for the people in the age group of 18 to 44 and have directed the available stock of doses for the above-45 age group.
Maharashtra on Wednesday (May 12, 2021) decided to suspend its third phase of vaccination drive, while Delhi also temporarily shut Covaxin administering centres for people in the age group of 18 to 44 years as it has run out of stock.
Global tenders to meet needs
On the other hand, Tamil Nadu government announced global tenders for procurement of COVID-19 vaccines, followed by reports of the Rajasthan government mulling over similar steps.
Other than this states like Uttar Pradesh, Maharashtra, Karnataka, Telangana and Andhra Pradesh have already opted for global tenders to meet their needs. Uttarakhand officials said the state will import 20 lakh doses of Sputnik vaccine over the next two months.
Need to ramp up domestic production
The Serum Institute and Bharat Biotech have submitted their production plan for the next four months to the central government. The plan suggests that the pharmaceutical companies can scale it up to 10 crore and 7.8 crore doses respectively by August.
The Hyderabad-based Bharat Biotech’s indigenously developed Covaxin and Oxford-AstraZeneca’s Covishield, being manufactured by the Pune-based Serum Institute of India (SII), are currently being used in India’s inoculation drive against the coronavirus.
Focus more on second dose vaccinations: Harsh Vardhan
While the vaccination drive appeared to be faltering in numerous states, Union Health Minister Harsh Vardhan urged them to first focus more on second dose COVID-19 vaccinations, stressing on the fact that India is the fastest country globally to reach the landmark of administering 17 crore doses in 114 days.
The minister pointed out that of this, while 13.66 crore people have been administered the first dose, the second dose has been administered to only 3.86 crore.
“Hence, it is very important that we first focus more on second dose vaccinations. States should not lose sight of those who are to get the second dose of the COVID vaccine.
“Seventy percent ought to be allocated to meet the requirement of the second dose, while 30 percent ought to be reserved for the first dose,” he was quoted as saying in a statement.
Insufficient supply of vaccine
Maharashtra Health Minister Rajesh Tope said that SII has informed it that it would be able to provide 1.5 crore Covishield vaccines to the state only May 20 onwards.
“There is no sufficient supply of vaccine vials by the Centre for inoculation of above-45 age group people. Hence, the state cabinet decided to divert the stock, purchased for the 18-44 age group, for the above-45 age group. Therefore, we are suspending the inoculation of the 18-44 age group for some period,” Tope said.
On the other hand, Delhi Deputy Chief Minister Manish Sisodia said Bharat Biotech has informed the state government that it cannot provide “additional” Covaxin doses to the national capital.
“The Covaxin manufacturer has in a letter said that it cannot provide Delhi government vaccines due to unavailability, under the instruction of concerned government officials. It means that the central government is controlling the supply of the vaccine,” Sisodia said.
Who is to blame- Centre or states?
The Joint Secretary in the Union health ministry Lav Agarwal on Tuesday denied that the Centre had any role to play in the purchase of vaccines by the states.
Bharat Biotech Joint Managing Director Suchitra Ella said the company has already dispatched Covaxin lots to 18 states on May 10 and said it was disheartening to listen to some states complaining about Bharat Biotech’s intentions regarding the supply of COVID vaccine.
“50 of our employees are off work due to covid, yet we continue to work under pandemic lockdowns 24×7 for U,” she said in a tweet.
Demand versus supply- companies unable to meet demand
The Tamil Nadu government said an allocation of about 13 lakh vaccine doses to the state is not sufficient to cover all those in the 18-45 age group.
Hence, “the government has decided to go in for global bids to procure vaccines,” an official CM office read, however, said it would have been better if the central government had procured the vaccines by floating global tenders and distributing them to states.
The Odisha government informed the Centre that about 22 lakh people in the state are waiting for the second shot and therefore the state requires at least 25 lakh doses of COVID-19 vaccines.
Kerala also urged the Centre to provide more vaccines. Chief Minister P Vijayan underlined the need for prioritising the vaccination of those in the 18 to 45 age group from the vaccine ordered by the state as there is not enough stock for everyone to be vaccinated in one go.
Blame-game continues over COVID-19
The issue of shortage of vaccines has been used by parties like the Congress, Shiv Sena and the AAP to target the BJP-led central government. They have blamed the current situation on the export of vaccines to other countries early this year.
The ruling BJP, however, accused the Congress and the Aam Aadmi Party (AAP) on Wednesday of spreading misinformation on India’s vaccination programme and said over 84 percent of the vaccine doses sent abroad were part of the commercial and licensing liabilities of the two Indian manufacturers.
Leaders of 12 opposition parties wrote to PM Modi
Meanwhile, leaders of 12 opposition parties wrote to Prime Minister Narendra Modi, seeking a free mass vaccination campaign against coronavirus among other steps in the wake of the COVID crisis.
“Procure vaccines centrally from all available sources – global and domestic. Immediately begin a free, universal mass vaccination campaign across the country. Invoke compulsory licensing to expand domestic vaccine production. Spend budgetary allocation of Rs 35,000 crores for the vaccines,” the leaders said in their letter.
The signatories to the joint letter include Congress president Sonia Gandhi, former prime minister and JDS leader H D Deve Gowda and NCP supremo Sharad Pawar. Others include chief ministers Uddhav Thackeray (Shiv Sena), Mamata Banerjee (TMC), MK Stalin (DMK), and Hemant Soren (JMM).
Meanwhile, the Union Health Ministry revealed that the total number of COVID-19 vaccine doses administered in the country has gone past 17.70 crore.
Live TV
$(function() { return $("[data-sticky_column]").stick_in_parent({ parent: "[data-sticky_parent]" }); });
reset_scroll = function() { var scroller; scroller = $("body,html"); scroller.stop(true); if ($(window).scrollTop() !== 0) { scroller.animate({ scrollTop: 0 }, "fast"); } return scroller; };
window.scroll_it = function() { var max; max = $(document).height() - $(window).height(); return reset_scroll().animate({ scrollTop: max }, max * 3).delay(100).animate({ scrollTop: 0 }, max * 3); };
window.scroll_it_wobble = function() { var max, third; max = $(document).height() - $(window).height(); third = Math.floor(max / 3); return reset_scroll().animate({ scrollTop: third * 2 }, max * 3).delay(100).animate({ scrollTop: third }, max * 3).delay(100).animate({ scrollTop: max }, max * 3).delay(100).animate({ scrollTop: 0 }, max * 3); };
$(window).on("resize", (function(_this) { return function(e) { return $(document.body).trigger("sticky_kit:recalc"); }; })(this));
}).call(this);
googletag.pubads().setTargeting('category', ["article","India","COVID-19","Coronavirus","COVID-19 Vaccination Drive","COVID-19 Vaccination Phase 3","Serum Institute","Bharat Biotech"]); googletag.pubads().enableLazyLoad({ fetchMarginPercent: 50, renderMarginPercent: 50, mobileScaling: 2.0 }); googletag.pubads().disableInitialLoad(); googletag.pubads().enableAsyncRendering(); googletag.pubads().set('page_url','https://zeenews.india.com/'); googletag.pubads().collapseEmptyDivs(); googletag.enableServices(); }); googletag.cmd.push(function() { googletag.display('div-article-rhs-atf-ad'); }); googletag.cmd.push(function() { googletag.display('div-gpt-ad-1504525832454-0'); }); googletag.cmd.push(function() { googletag.display('div-gpt-ad-1504525832454-2'); }); googletag.cmd.push(function() { googletag.display('div-gpt-ad-1504526235866-6'); });
} on_load_google_ad(); function sendAdserverRequest() { try { if (pbjs && pbjs.adserverRequestSent) return; googletag.cmd.push(function() { googletag.pubads().refresh(); }); } catch (e) {
googletag.cmd.push(function() { googletag.pubads().refresh(); }); } } setTimeout(function() { sendAdserverRequest(); }, 5000);
function on_load_fb_twitter_widgets(){ (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.9"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
window.twttr = (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0], t = window.twttr || {}; if (d.getElementById(id)) return t; js = d.createElement(s); js.id = id; js.src = "https://platform.twitter.com/widgets.js"; fjs.parentNode.insertBefore(js, fjs); t._e = []; t.ready = function(f) {
t._e.push(f); }; return t; }(document, "script", "twitter-wjs")); }
//setTimeout(function() { on_load_google_ad(); }, 5000);
setTimeout(function() {
on_load_fb_twitter_widgets();
}, 5000);
Source link
